Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Stem Cell, Cell Culture
DISEASE(S): Brain Glioblastoma Multiforme
SUBMITTER: Xiuxing Wang
LAB HEAD: Xiuxing Wang
PROVIDER: PXD061009 | Pride | 2025-05-07
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
2907.raw | Raw | |||
IgG.dat | Other | |||
IgG.raw | Raw | |||
SRGN.dat | Other | |||
checksum.txt | Txt |
Items per page: 5 1 - 5 of 5 |
Lu Chenfei C Kang Tao T Zhang Junxia J Yang Kailin K Liu Yang Y Song Kefan K Lin Qiankun Q Dixit Deobrat D Gimple Ryan C RC Zhang Qian Q Shi Zhumei Z Fan Xiao X Wu Qiulian Q Li Daqi D Shan Danyang D Gao Jiancheng J Gu Danling D You Hao H Li Yangqing Y Yang Junlei J Zhao Linjie L Qiu Zhixin Z Yang Hui H Zhao Ningwei N Gao Wei W Tao Weiwei W Lu Yingmei Y Chen Yun Y Ji Jing J Zhu Zhe Z Kang Chunsheng C Man Jianghong J Agnihotri Sameer S Wang Qianghu Q Lin Fan F Qian Xu X Mack Stephen C SC Hu Zhibin Z Li Chaojun C Taylor Michael D MD Liu Ning N Zhang Nu N Lu Ming M You Yongping Y Rich Jeremy N JN Zhang Wei W Wang Xiuxing X
Nature communications 20250326 1
Glioblastoma (GBM) is the most lethal primary brain tumor with intra-tumoral hierarchy of glioblastoma stem cells (GSCs). The heterogeneity of GSCs within GBM inevitably leads to treatment resistance and tumor recurrence. Molecular mechanisms of different cellular state GSCs remain unclear. Here, we find that classical (CL) and mesenchymal (MES) GSCs are enriched in reactive immune region and high CL-MES signature informs poor prognosis in GBM. Through integrated analyses of GSCs RNA sequencing ...[more]